New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

FDA cracks down on supplements containing DMBA

The 14 warning letters sent by the agency address 17 products that contain the ingredient.

The FDA issued warning letters to 14 companies regarding a total of 17 products for which the product labeling identifies DMBA as a dietary ingredient.

The agency considers these products to be adulterated because they are labeled as containing a new dietary ingredient, DMBA, and because they have not satisfied the conditions to include DMBA as a dietary ingredient.

Under existing law, including the Dietary Supplement Health and Education Act passed by Congress in 1994, the FDA can take action to remove products from the market, but the agency must first establish that such products are adulterated or misbranded.

The warning letters were sent to the following companies, with the products impacted listed next to them.

DSEO LLC (Products: HybriLean and PREAMP)

Discover Our Content Hub
Access Healthcare Packaging's free educational content library!
Read More
Discover Our Content Hub
Test Your Supply Chain Smarts
Take Healthcare Packaging's supply chain quiz to prove your knowledge!
Read More
Test Your Supply Chain Smarts